Last week, readers were most interested in a story about how priorities for the lab industry could play out depending on election results.

Last week, readers were most interested in a story about how priorities for the lab industry could play out depending on election results.

UK-based Cizzle Biotechnology signed the licensing agreement with its US-based partner, Cizzle Bio, for the commercialization of early cancer detection tests.

The automated real-time PCR-based test detects DNA from the virus that causes mpox using a dual-target approach and runs on Roche's high-throughput Cobas 6800/8800 systems. The EUL process is intended ...

The EU has awarded the researchers €188,000 to support the project through September 2026, by which time they hope to have a validated prototype ready.

Endometriosis is associated with debilitating pain and increased risk of cancer and autoimmune diseases, yet diagnosis remains out of reach for many patients.

The Maryland-based firm reported in a recent proof-of-concept study that It used protease biomarkers to identify patients ...

The field's rapid advances make securing reimbursement an important area of focus, researchers in a recent commentary argued.

In an open letter, the organization called on Danaher and its subsidiary Cepheid to further lower the price of its Xpert MTB/RIF Ultra tuberculosis test.

The assay evaluates a patient's tumor immune profile against Cofactor's high-dimensional RNA-based Health Expression Models to predict a patient's therapy response.

Aspira can now offer the test, intended for assessing ovarian cancer risk in women with an adnexal mass, to patients in New York state.